Phytanic acid derivative compositions
AssigneeRoche Vitamins Inc.
InventorsBeat Fluehmann, Willi Hunziker
Life of this patent
Estimating the term…
Abstract
The present invention is a method for the treatment or prevention of preferably non-insulin dependent (NIDDM or so-called Type II) diabetes mellitus, or other conditions associated with impaired glucose tolerance such as obesity, and in particular to the use of phytanic acid derivatives for the said treatment and/or prevention. A method of making a composition for the treatment or prevention of non-insulin dependent diabetes mellitus and related diseases comprising combining phytanic acid or derivatives thereof with a pharmaceutically acceptable additive or adjuvant, and a composition for the treatment or prevention of non-insulin dependent diabetes mellitus comprising phytanic acid or derivatives thereof are also provided.
Claims6
A composition for the treatment of non-insulin dependent diabetes mellitus comprising from about 0.1 to about 1000 mg of phytanic acid or a derivative thereof and a pharmaceutically acceptable carrier.
A dietary supplement comprising a composition for the treatment of non-insulin dependent diabetes mellitus comprising from about 0.1 to about 1000 mg of phytanic acid or a derivative thereof and an additive or adjuvant.
Dependencies are inferred from the claim text.